Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Growth Metrics
Income Statement
Others
Ratios

Cresco Labs (CRLBF) Payables (2019 - 2025)

Cresco Labs' Payables history spans 7 years, with the latest figure at $27.3 million for Q4 2025.

  • For Q4 2025, Payables rose 6.8% year-over-year to $27.3 million; the TTM value through Dec 2025 reached $27.3 million, up 6.8%, while the annual FY2025 figure was $27.3 million, 6.8% up from the prior year.
  • Payables reached $27.3 million in Q4 2025 per CRLBF's latest filing, up from $25.6 million in the prior quarter.
  • In the past five years, Payables ranged from a high of $39.4 million in Q4 2023 to a low of $25.6 million in Q4 2024.
  • Average Payables over 5 years is $30.5 million, with a median of $28.1 million recorded in 2022.
  • Peak YoY movement for Payables: soared 40.26% in 2023, then tumbled 35.07% in 2024.
  • A 5-year view of Payables shows it stood at $32.3 million in 2021, then dropped by 12.97% to $28.1 million in 2022, then surged by 40.26% to $39.4 million in 2023, then crashed by 35.07% to $25.6 million in 2024, then grew by 6.8% to $27.3 million in 2025.
  • Per Business Quant, the three most recent readings for CRLBF's Payables are $27.3 million (Q4 2025), $25.6 million (Q4 2024), and $39.4 million (Q4 2023).